A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

Clinical trial NCT05909527 · WITHDRAWN

Trial details

NCT number: NCT05909527
Sponsor: Guangzhou Bio-gene Technology Co., Ltd
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-Cell Acute Lymphocytic Leukemia

Start date: 2023-05-01
Primary completion: 2028-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.